Anavex Life Sciences Corp (AVXL)

[imho]

In no way do 11/7 results need to meet or exceed 83% in order to be great

Donepezil only works (and not very well) in 50% of patients

A drug that helped 50-60% of AD patients at twice the efficacy of donepezil would be worth many billions of dollars

AVXL does not need 83% at 4x efficacy of donepezil in order to have a great great data readout on 11/7

Agree. Safety and proper dosage are major factors, as well.

Ultimately, I would like to see the FDA or some external authority, make positive comments about the drug or the trials. I mean, it's one thing for laymen or even experts debate, but an external authority (patent office, FDA, etc) speaks volumes.

IMHO